Post

New research · Ophthalmology
Japanese journal of ophthalmology · 2d
Cohort studyJapanese journal of ophthalmology · 2026

Epidemiology and treatment trends of retinopathy of prematurity: a multi-center study involving four Asian centers and one European center (2016-2023).

Yi-Hsuan Tseng, Tapas Ranjan Padhi, Souvik Bhunia … Wei-Chi Wu
Read paper
OphthalmologyCohort study

Bevacizumab was the most common anti-VEGF drug used to treat retinopathy of prematurity

Epidemiology and treatment trends of retinopathy of prematurity: a multi-center study involving four Asian centers and one European center (2016-2023).

Yi-Hsuan Tseng … Wei-Chi Wu
Japanese journal of ophthalmology · 2026
Purpose

To investigate regional differences in the epidemiology and treatment of retinopathy of prematurity (retinopathy of prematurity) from 2016 to 2023.

Methods

Retrospective Premature infants screened for retinopathy of prematurity at a single tertiary referral center in each of five countries/regions (Taiwan, Hong Kong, Singapore, India, and Portugal) during the study period.

n = 15,031 premature infants
Results
87.3%
of the anti-VEGF drugs used, bevacizumab was picked most often
n = 15,031 premature infants
More results

Demographics varied significantly (p <0.001); India had the highest gestational age and birth weight, and the lowest proportion of very low birth weight and extremely low birth weight infants with type 1 retinopathy of prematurity (p <0.001).

More results

Hong Kong had the lowest retinopathy of prematurity incidence, while Singapore showed a significant increase over time (p = 0.003).

Type 1 retinopathy of prematurity rates were higher in Taiwan and India than in Hong Kong and Singapore, with a significant decline observed only in Taiwan (p = 0.005).

“
Conclusion · 1 of 2

From 2016 to 2023, retinopathy of prematurity incidence and treatment showed significant regional differences. retinopathy of prematurity increased in Singapore, while type 1 retinopathy of prematurity decreased significantly in Taiwan.

Conclusion · 2 of 2

Although anti-VEGF therapy has become more common, laser treatment remains dominant in Hong Kong.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment